TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given ChallengesSeeking Alpha • 05/05/25
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue GuidanceGlobeNewsWire • 05/05/25
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business UpdateGlobeNewsWire • 04/30/25
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual MeetingGlobeNewsWire • 04/10/25
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical JournalsGlobeNewsWire • 04/07/25
These Insurance Stocks And Biotech Leader Hit New Highs As Stock Market CrumblesInvestors Business Daily • 03/21/25
Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?Zacks Investment Research • 03/17/25
Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-CelSeeking Alpha • 03/15/25
S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market ShakeoutInvestors Business Daily • 03/08/25
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual MeetingGlobeNewsWire • 03/07/25
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025Invezz • 03/04/25